SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$7.77
+2.94%
Mkt Cap $1.12B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.40 – $3.20
Implied Upside
-64.0%
Consensus $2.80 vs current $7.77
NASDAQ·Healthcare·Biotechnology
$7.77
+2.94%
Mkt Cap $1.12B
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.40 – $3.20
-64.0%
Consensus $2.80 vs current $7.77